Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06944899 · ClinicalTrials.gov registry record · NA
NO Sensor to Record Wound Data in Acute or Chronic Wounds
A NA study of Volumetric Muscle Loss, sponsored by Stephen Badylak.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06944899: Completed NA study of Volumetric Muscle Loss, sponsored by Stephen Badylak.
NCT06944899 is a NA study of Volumetric Muscle Loss that has completed, run by Stephen Badylak. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06944899, a NA study of Volumetric Muscle Loss, has completed, sponsored by Stephen Badylak.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the ability of a Nitric Oxide (NO) Sensor to collect NO measurement data from an open wound. Previous research suggests that NO levels may indicate the stage of healing the wound is in. This study is being done to determine if the NO Sensor can measure how much NO is in a participant's wound. The researcher will place the NO Sensor into a participant's wound to collect NO measurements for 30-60 minutes. The participant will then have 2 follow-up appointments to see how the wound heals over time.
Conditions Studied
Interventions
- DEVICE NO Sensor
Study Locations (1)
Pennsylvania
- UPMC Mercy - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2025-10-28 |
| Phase | NA |
What the finished NCT06944899 record still lists
NCT06944899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Volumetric Muscle Loss appearing as the primary indexed condition, and to 1 intervention - of which NO Sensor is the first listed.
NCT06944899 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06944899 about?
NCT06944899 is a clinical study titled "NO Sensor to Record Wound Data in Acute or Chronic Wounds". The purpose of this research is to evaluate the ability of a Nitric Oxide (NO) Sensor to collect NO measurement data from an open wound. Previous research suggests that NO levels may indicate the stage of healing the wound is in. This study is being done to determine if the NO Sensor can measure how...
What is the current status of trial NCT06944899?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-20. Estimated completion is 2025-10-28.
What conditions does trial NCT06944899 study?
This clinical trial studies the following conditions: Volumetric Muscle Loss.
What interventions are being tested in trial NCT06944899?
The interventions under investigation include: NO Sensor (DEVICE).
Who is sponsoring clinical trial NCT06944899?
This trial is sponsored by Stephen Badylak, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06944899 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06944899's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI